Identification of the central tolerance checkpoint for autoreactive proteinase 3+ B cells in human bone marrow

Major target antigens of ANCA-associated vasculitis (AAV) are myeloperoxidase (MPO) and proteinase 3 (PR3). High-affinity MPO- and PR3-ANCA immunoglobulins are produced by antigen-experienced, class-switched autoreactive B cells. To prevent autoreactivity, B cells are subjected to several self-tolerance checkpoints, from the early immature stages in the bone marrow (BM), collectively called "central tolerance", to late mature stages, collectively called "peripheral tolerance"; the latter was recently elucidated for autoreactive PR3<sup>+</sup> B cells. Here we investigated central tolerance controlling immature PR3<sup>+</sup>B cells in the BM before their migration into the periphery as transitional B cells. We applied an established flow cytometry-based method using labeled recombinant PR3 (rPR3) to identify the PR3<sup>+</sup>B cells to compare the phenotype of PR3<sup>+</sup>B cells in paired samples of BM mononuclear cells (BMMC) and peripheral blood mononuclear cells (PBMC) of non-vasculitis controls (No-AAV), and PBMC of patients with PR3-ANCA-associated vasculitis (PR3-AAV). We observed that the proportion of PR3<sup>+</sup>B cells within BMMC was higher (median [IQR]; 1.98 % [1.77-2.75]) than within PBMC of No-AAV (0.9 % [0.63-1.44], p < 0.01 by paired comparison) and similar to their proportion within PBMC of patients with PR3-AAV (1.82 % [1.66-3.21]; p > 0.05). Within CD24<sup>++</sup>CD38<sup>++</sup> B cells, the subset of B cell migrating from BM to the periphery, BMMC contained a greater proportion of PR3<sup>+</sup>B cells as compared to PBMC in No-AAV (3.35 % [1.99-4.92] versus 1.23 % [0.62-1.55], p < 0.01), showing different surface markers of maturation (i.e. higher proportion of CD27<sup>-</sup>CD10<sup>+</sup> and lower expression of CD21, IgD, IgM). Importantly, we observed a significant decline of the PR3<sup>+</sup> fraction from the immature subset (IgD<sup>-</sup>IgM<sup>+</sup>; 2.80 % [1.23-4.02]) to the early transitional subset (IgD<sup>+</sup>IgM<sup>+</sup>; 1.76 % [0.96-2.68], p < 0.01) in BMMC, while no significant reduction was observed between the early transitional of BMMC and the transitional compartment of PBMC in No-AAV (1.26 % [0.62-1.56], p > 0.05). In conclusion, to prevent PR3-related autoimmunity, autoreactive PR3<sup>+</sup>B cells pass a stringent selection in the BM, and their removal by central tolerance checkpoint activity occurs mainly between T1-like/immature to T2-like/early transitional B cells of BMMC.

Authors

Institutions

Publication Details

Journal
Journal of Autoimmunity
Published
2024-11-15
DOI
https://doi.org/10.1016/j.jaut.2024.103330
Citations
1
Primary Topic
Vasculitis and related conditions
Type
article
Field-Weighted Citation Impact
0.42
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Identification of the central tolerance checkpoint for autoreactive proteinase 3+ B cells in human bone marrow

Divi Cornec, Isabella Pesce, Ulrich Specks, Guido Grandi et al.
1 citations
Journal of Autoimmunity
Vasculitis and related conditions
0.42
article

Identification of the central tolerance checkpoint for autoreactive proteinase 3+ B cells in human bone marrow

Divi Cornec, Isabella Pesce, Ulrich Specks, Guido Grandi, Michele Tomasi, Alvise Berti, Roberto Bortolotti, Sophie Hillion, Enrico Lista, Giuseppe Paolazzi, Anna Guella
article en
1 citations

Abstract

Major target antigens of ANCA-associated vasculitis (AAV) are myeloperoxidase (MPO) and proteinase 3 (PR3). High-affinity MPO- and PR3-ANCA immunoglobulins are produced by antigen-experienced, class-switched autoreactive B cells. To prevent autoreactivity, B cells are subjected to several self-tolerance checkpoints, from the early immature stages in the bone marrow (BM), collectively called "central tolerance", to late mature stages, collectively called "peripheral tolerance"; the latter was recently elucidated for autoreactive PR3<sup>+</sup> B cells. Here we investigated central tolerance controlling immature PR3<sup>+</sup>B cells in the BM before their migration into the periphery as transitional B cells. We applied an established flow cytometry-based method using labeled recombinant PR3 (rPR3) to identify the PR3<sup>+</sup>B cells to compare the phenotype of PR3<sup>+</sup>B cells in paired samples of BM mononuclear cells (BMMC) and peripheral blood mononuclear cells (PBMC) of non-vasculitis controls (No-AAV), and PBMC of patients with PR3-ANCA-associated vasculitis (PR3-AAV). We observed that the proportion of PR3<sup>+</sup>B cells within BMMC was higher (median [IQR]; 1.98 % [1.77-2.75]) than within PBMC of No-AAV (0.9 % [0.63-1.44], p < 0.01 by paired comparison) and similar to their proportion within PBMC of patients with PR3-AAV (1.82 % [1.66-3.21]; p > 0.05). Within CD24<sup>++</sup>CD38<sup>++</sup> B cells, the subset of B cell migrating from BM to the periphery, BMMC contained a greater proportion of PR3<sup>+</sup>B cells as compared to PBMC in No-AAV (3.35 % [1.99-4.92] versus 1.23 % [0.62-1.55], p < 0.01), showing different surface markers of maturation (i.e. higher proportion of CD27<sup>-</sup>CD10<sup>+</sup> and lower expression of CD21, IgD, IgM). Importantly, we observed a significant decline of the PR3<sup>+</sup> fraction from the immature subset (IgD<sup>-</sup>IgM<sup>+</sup>; 2.80 % [1.23-4.02]) to the early transitional subset (IgD<sup>+</sup>IgM<sup>+</sup>; 1.76 % [0.96-2.68], p < 0.01) in BMMC, while no significant reduction was observed between the early transitional of BMMC and the transitional compartment of PBMC in No-AAV (1.26 % [0.62-1.56], p > 0.05). In conclusion, to prevent PR3-related autoimmunity, autoreactive PR3<sup>+</sup>B cells pass a stringent selection in the BM, and their removal by central tolerance checkpoint activity occurs mainly between T1-like/immature to T2-like/early transitional B cells of BMMC.

Journal of AutoimmunityVol. 149
Inserm (FR), Université de Bretagne Occidentale (FR), University of Trento (IT), Ospedale Santa Chiara (IT), Mayo Clinic in Arizona (US), Centre Hospitalier Régional Universitaire de Brest (FR), Mayo Clinic in Florida (US)
Zero hunger
Openalex Percentile: Top 31%
Vasculitis and related conditions
0.42
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.